Diana Brainard, CEO: Kalaris Therapeutics KLRS Sell · Filed 24/10/23

Trade details

Type: Insider sale
Amount: $7,606.56
Shares · price: 9,752 sh · $0.78 a share
Held after: 742,678 sh
Stock: Kalaris Therapeutics KLRS
Person: Diana BrainardCEO
Trade date: 24/10/21
Filed: 24/10/23
Days to filing: 2 days

Sold 1.3% of holdings

Share of holding sold: 1.3%

Kalaris Therapeutics trades, last 26 weeks

What else happened in Kalaris Therapeutics around then

Filed or reported within 30 days of the trade day · 24/09/21~24/11/20

Diana Brainard's recent trades

Diana BrainardCEO
SellKalaris Therapeutics
Sell
Kalaris Therapeutics
KLRS
$4,788
8,706 sh
$4,788
Filed 24/11/20
Traded 24/11/19
Diana BrainardCEO
SellKalaris Therapeutics
Sell
Kalaris Therapeutics
KLRS
$9,124
10,609 sh
$9,124
Filed 24/11/06
Traded 24/11/05
Diana BrainardCEO
SellKalaris Therapeutics
Sell
Kalaris Therapeutics
KLRS
$1,209
1,493 sh
$1,209
Filed 24/10/04
Traded 24/10/03
Diana BrainardCEO
SellKalaris Therapeutics
Sell
Kalaris Therapeutics
KLRS
$3,989
5,390 sh
$3,989
Filed 24/08/22
Traded 24/08/20
Diana BrainardCEO
SellKalaris Therapeutics
Sell
Kalaris Therapeutics
KLRS
$2,349
3,091 sh
$2,349
Filed 24/08/20
Traded 24/08/19